We hypothesized that by linking an apoB100-derived peptide (25 AA; ApoB-P) to the NPs surface [30], the decorated NPs will be targeted to the tumor’s ECM through their interaction with PGs in the tumor’s microenvironment. The gene discussed is APOB; the disease is neoplasm.